Uncategorized

To address lack of regulatory standards, NGOs test CBD products in Europe

The CBD market in Europe faces a challenge that would look familiar to many U.S. producers: Its popularity is on the rise, despite lack of clear rules and industrywide standards. For consumers, this means legitimate products can often be found right next to others with significantly less CBD than advertised or with potentially harmful contaminants. This is especially […]

Read More

Canadian investors see hemp as way into US markets

The hemp industry continues to be a top investment target for well-capitalized Canadian cannabis companies. But that doesn’t mean they’re all looking to grow the plant. Organigram CEO Greg Engel, whose New Brunswick-based company began trading this week on the Nasdaq, says CBD offers a big opportunity to enter U.S. markets. However, he added his […]

Read More

FSD Pharma reveals hemp purchase agreement after Auxly deal collapses

Ontario-based FSD Pharma has agreed to buy 1,000 kilograms (2,200 pounds) of hemp on a contractual basis from a farmer in the province for CBD extraction at the company’s Cobourg facility. The move comes after the breakdown last week of an agreement between FSD and marijuana company Auxly for the purchase of 49.9% of the […]

Read More

Target’s CBD sales reversal roils hemp industry

A decision by Target Corp. to start selling CBD supplements last week had the hemp industry cheering – until the Minneapolis-based retail giant yanked the products. Target’s decision to stop selling CW Hemp supplements and oils followed a news release from the manufacturer, CW Hemp, saying the whole CBD industry “has officially gone mainstream.” Within […]

Read More